[Research progress in Ph-like childhood acute lymphoblastic leukemia]

Area of Science:

• Pediatric Oncology
• Hematology
• Molecular Biology

Background:

• Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) is a distinct subtype of B-lineage ALL.
• Ph-like ALL shares a gene expression profile with Philadelphia chromosome-positive ALL (Ph+ ALL).
• This subtype is characterized by diverse genetic alterations activating cytokine receptor and kinase signaling pathways.

Purpose of the Study:

• To review recent advancements in understanding Ph-like childhood ALL.
• To elucidate the genetic alterations, pathogenesis, and clinical features of Ph-like ALL.
• To explore potential therapeutic strategies for Ph-like childhood ALL.

Main Methods:

• Literature review of recent research progress on Ph-like ALL.
• Analysis of genetic alterations, molecular pathogenesis, and clinical characteristics.
• Evaluation of diagnostic measures and potential targeted therapies.

Main Results:

• Ph-like ALL accounts for 15% of pediatric high-risk B-ALL cases.
• It presents with adverse clinical features and a poor prognosis.
• Genetic abnormalities frequently involve cytokine receptor genes, kinase signaling, and transcription factors.

Conclusions:

• Targeted therapies, inspired by successful treatments for Ph+ ALL, show promise for Ph-like ALL.
• Further research into molecular cytogenetic abnormalities is crucial for developing effective treatments.
• Understanding the specific drivers of Ph-like ALL can guide personalized therapeutic approaches.